Aziz Nazha Discusses the Future of Treating Patients With MDS

October 1, 2015
Aziz Nazha

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).

Related Content:

CURE TVMDS
Psilocybin May Have Mental Health Benefits for Patients With Cancer
Putting an Emphasis on Patient Collaboration in MPN Treatment
CAR T-Cell Therapy Yescarta Continues to Demonstrate Durable Responses in Follicular Lymphoma